|
1
|
Cohen R, Mallet T, Gale M, Soltys R and
Loarte P: Portal vein thrombosis. Case Rep Vasc Med.
2015:8230632015.PubMed/NCBI
|
|
2
|
Winslow ER, Brunt LM, Drebin JA, Soper NJ
and Klingensmith ME: Portal vein thrombosis after splenectomy. Am J
Surg. 184:631–636. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Manzano-Robleda Mdel C, Barranco-Fragoso
B, Uribe M and Méndez-Sánchez N: Portal vein thrombosis: What is
new? Ann Hepatol. 14:20–27. 2015.PubMed/NCBI
|
|
4
|
Amitrano L, Guardascione MA, Brancaccio V,
Margaglione M, Manguso F, Iannaccone L, Grandone E and Balzano A:
Risk factors and clinical presentation of portal vein thrombosis in
patients with liver cirrhosis. J Hepatol. 40:736–741. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lixue D, Wujun W, Zhang Y, Sun Z, Haitian
H and Liu Q: Clinical analysis of portal vein thrombosis after
splenocaval shunt plus devascularization in treatment of portal
hypertension. Chin J Hepatobiliary Surg. 16:353–355. 2010.(In
Chinese).
|
|
6
|
Harmanci O and Bayraktar Y: Portal
hypertension due to portal venous thrombosis: Etiology, clinical
outcomes. World J Gastroenterol. 13:2535–2540. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Geng JG, Chen M and Chou KC: P-selectin
cell adhesion molecule in inflammation, thrombosis, cancer growth
and metastasis. Curr Med Chem. 11:2153–2160. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
André P, Hartwell D, Hrachovinovã I,
Saffaripour S and Wagner DD: Pro-coagulant state resulting from
high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA.
97:13835–13840. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Myers DD Jr, Schaub R, Wrobleski SK, Londy
FJ III, Fex BA, Chapman AM, Greenfield LJ and Wakefield TW:
P-selectin antagonism causes dose-dependent venous thrombosis
inhibition. Thromb Haemost. 85:423–429. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Myers D, Wrobleski S, Londy F, Fex B,
Hawley A, Schaub R, Greenfield L and Wakefield T: New and effective
treatment of experimentally induced venous thrombosis with
anti-inflammatory rPSGL-Ig. Thromb Haemost. 87:374–382. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eppihimer MJ and Schaub RG:
P-Selectin-dependent inhibition of thrombosis during venous stasis.
Arterioscler Thromb Vasc Biol. 20:2483–2488. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Théorêt JF, Bienvenu JG, Kumar A and Merhi
Y: P-selectin antagonism with recombinant p-selectin glycoprotein
ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding
to neutrophils induced by damaged arterial surfaces. J Pharmacol
Exp Ther. 298:658–664. 2001.PubMed/NCBI
|
|
13
|
Reyers I, Mussoni L, Donati MB and de
Gaetano G: Failure of aspirin at different doses to modify
experimental thrombosis in rats. Thromb Res. 18:669–674. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brill A, Fuchs TA, Chauhan AK, Yang JJ, De
Meyer SF, Köllnberger M, Wakefield TW, Lämmle B, Massberg S and
Wagner DD: von Willebrand factor-mediated platelet adhesion is
critical for deep vein thrombosis in mouse models. Blood.
117:1400–1407. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakase H, Heimann A and Kempski O:
Alterations of regional cerebral blood flow and oxygen saturation
in a rat sinus-vein thrombosis model. Stroke. 27:720–728. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seyed Mortaz SS, Golfam F, Khalaj AR,
Taheri HR and Kholdi N: The effect of distal vein branch ligation
in side-to-side arterivenous fistula on the patency rate and
complication in one year. Daneshvar Medicine. 16:19–24. 2009.
|
|
17
|
Xu Z, Lioi J, Mu J, Kamocka MM, Liu X,
Chen DZ, Rosen ED and Alber M: A multiscale model of venous
thrombus formation with surface-mediated control of blood
coagulation cascade. Biophys J. 98:1723–1732. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Khalid A, Azeez EA, Bhatti TH and Eshak Y:
Transcutanous electric nerve stimulation and deep venous
thrombosis. Anesthesia & Analgesia. 86:S121998. View Article : Google Scholar
|
|
19
|
Nosaka M, Ishida Y, Kimura A and Kondo T:
Time-dependent appearance of intrathrombus neutrophils and
macrophages in a stasis-induced deep vein thrombosis model and its
application to thrombus age determination. Int J Legal Med.
123:235–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fei Y, Zong GQ, Chen J and Liu RM:
Evaluation of the value of d-dimer, P-selectin, and platelet count
for prediction of portal vein thrombosis after devascularization.
Clin Appl Thromb Hemost. 22:471–475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bing Y, Zhao QH and Yu Z: Effect of
urokinase on vein wall remodeling after deep vein thrombosis in
rats. Di San Jun Yi Da Xue Xue Bao. 32:1970–1975. 2010.(In
Chinese).
|
|
23
|
Kyogashima M, Onaya J, Hara A and Taketomi
T: Sulfatide can markedly enhance thrombogenesis in rat deep vein
thrombosis model. Glycoconj J. 15:915–922. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nosaka M, Ishida Y, Kimura A and Kondo T:
Immunohistochemical detection of MMP-2 and MMP-9 in a
stasis-induced deep vein thrombosis model and its application to
thrombus age estimation. Int J Legal Med. 124:439–444. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burcharth F: Percutaneous transhepatic
catheterization of the portal venous system. Springer. (Japan).
1991. View Article : Google Scholar
|
|
26
|
Furie B and Furie BC: Role of platelet
P-selectin and microparticle PSGL-1 in thrombus formation. Trends
Mol Med. 10:171–178. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bedard PW, Clerin V, Sushkova N,
Tchernychev B, Antrilli T, Resmini C, Keith JC Jr, Hennan JK, Kaila
N, Debernardo S, et al: Characterization of the novel P-selectin
inhibitor PSI-697
[2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h]
quinoline-4-carboxylic acid] in vitro and in rodent models of
vascular inflammation and thrombosis. J Pharmacol Exp Ther.
324:497–506. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miszti-Blasius K, Debreceni IB, Felszeghy
S, Dezso B and Kappelmayer J: Lack of P-selectin glycoprotein
ligand-1 protects mice from thrombosis after collagen/epinephrine
challenge. Thromb Res. 127:228–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Myers DD Jr, Henke PK, Wrobleski SK,
Hawley AE, Farris DM, Chapman AM, Knipp BS, Thanaporn P, Schaub RG,
Greenfield LJ and Wakefield TW: P-selectin inhibition enhances
thrombus resolution and decreases vein wall fibrosis in a rat
model. J Vasc Surg. 36:928–938. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McEver RP: P-selectin and PSGL-1:
Exploiting connections between inflammation and venous thrombosis.
Thromb Haemost. 87:364–365. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kneuer C, Ehrhardt C, Radomski MW and
Bakowsky U: Selectins-potential pharmacological targets? Drug
Discov Today. 11:1034–1040. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Marder VJ and Sherry S: Thrombolytic
therapy: Current status. N Engl J Med. 318:1512–1520. 1988.
View Article : Google Scholar : PubMed/NCBI
|
